Resources to help you get started with DUPIXENT®
PATIENT RESOURCES

I’ve been prescribed DUPIXENT® for:

    Getting Started on DUPIXENT®

    A guide for people and caregivers of people with moderate-to-severe atopic dermatitis

    Instructions for Use: DUPIXENT® 200 mg pre-filled syringe with needle shield

    Instructions for Use: DUPIXENT® 200 mg pre-filled pen

    Instructions for Use: DUPIXENT® 300 mg pre-filled syringe with needle shield

    Instructions for Use: DUPIXENT® 300 mg pre-filled pen

    IMPORTANT NOTE: The DUPIXENT® pre-filled pen is not intended for use in pediatrics below 2 years of age. For children aged 6 months to 2 years of age, contact your doctor who will prescribe the appropriate DUPIXENT® pre-filled syringe with needle shield. In children 6 months to less than 12 years of age, DUPIXENT® should be given by a caregiver. In children 12 years of age and older, it is recommended that DUPIXENT® be administered by or under supervision of an adult.

    Getting Started on DUPIXENT®

    A guide for people and caregivers of people with severe type 2/eosinophilic or oral corticosteroid (OCS)-dependent asthma

    Instructions for Use: DUPIXENT® 200 mg pre-filled syringe with needle shield

    Instructions for Use: DUPIXENT® 200 mg pre-filled pen

    Instructions for Use: DUPIXENT® 300 mg pre-filled syringe with needle shield

    Instructions for Use: DUPIXENT® 300 mg pre-filled pen

    In children 6 months to less than 12 years of age, DUPIXENT® should be given by a caregiver. In children 12 years of age and older, it is recommended that DUPIXENT® be administered by or under supervision of an adult.

    Getting Started on DUPIXENT®

    A guide for people and caregivers of people with chronic obstructive pulmonary disease

    Instructions for Use: DUPIXENT® 300 mg pre-filled syringe with needle shield

    Instructions for Use: DUPIXENT® 300 mg pre-filled pen

    Getting Started on DUPIXENT®

    A guide for people and caregivers of people with severe chronic rhinosinusitis with nasal polyposis

    Instructions for Use: DUPIXENT® 300 mg pre-filled syringe with needle shield

    Instructions for Use: DUPIXENT® 300 mg pre-filled pen

    Getting Started on DUPIXENT®

    A guide for people and caregivers of people with eosinophilic esophagitis

    Instructions for Use: DUPIXENT® 300 mg pre-filled syringe with needle shield

    Instructions for Use: DUPIXENT® 300 mg pre-filled pen

    Getting Started on DUPIXENT®

    A guide for people and caregivers of people with moderate-to-severe prurigo nodularis

    Instructions for Use: DUPIXENT® 300 mg pre-filled syringe with needle shield

    Instructions for Use: DUPIXENT® 300 mg pre-filled pen

    Getting Started on DUPIXENT®

    A guide for people and caregivers of people with chronic spontaneous urticaria

    Instructions for Use: DUPIXENT® 200 mg pre-filled syringe with needle shield

    Instructions for Use: DUPIXENT® 200 mg pre-filled pen

    Instructions for Use: DUPIXENT® 300 mg pre-filled syringe with needle shield

    Instructions for Use: DUPIXENT® 300 mg pre-filled pen

    In children 6 months to less than 12 years of age, DUPIXENT® should be given by a caregiver. In children 12 years of age and older, it is recommended that DUPIXENT® be administered by or under supervision of an adult.

LEARN HOW TO ADMINISTER DUPIXENT®
  • Using the pre-filled pen

    Watch this video if you’re a patient and want to learn how to inject DUPIXENT®

     

    View transcript

    Watch this video if you’re a caregiver and want to learn how to inject DUPIXENT®

     

    View transcript

  • Using the pre-filled syringe with needle shield

    Watch this video if you’re a patient and want to learn how to inject DUPIXENT®

     

    View transcript

    Watch this video if you’re a caregiver and want to learn how to inject DUPIXENT®

     

    View transcript

WE ARE YOUR CARE COMPANION

Freedom Support Program 1-844-216-1181, Monday to Friday, 8 AM to 8 PM, Eastern Standard Time. Personalized support. Specialized care. Passionate team.

DUPIXENT® Resources

What is DUPIXENT® used for?

Atopic Dermatitis

  • To treat patients aged 6 months and older with moderate-to-severe atopic dermatitis, also known as atopic eczema. DUPIXENT® can be used with or without corticosteroid creams and/or ointments applied to the skin to help reduce inflammation.
  • It is not known if DUPIXENT® is safe and effective in children with atopic dermatitis below the age of 6 months

Asthma

  • To maintain treatment of patients aged 6 years and older with severe asthma with a type 2/eosinophilic phenotype or oral corticosteroid (OCS)‑dependent asthma, whose asthma is not controlled with their current asthma medicines. DUPIXENT® should be used in addition to other asthma medicines.
  • DUPIXENT® is not used to treat sudden breathing problems 
  • It is not known if DUPIXENT® is safe and effective in children with asthma below the age of 6 years

Chronic Obstructive Pulmonary Disease

  • In addition to other medicines for maintenance treatment of adults with chronic obstructive pulmonary disease (COPD) associated with raised eosinophil levels
  • It is not known if DUPIXENT® is safe and effective in children with COPD below age of 18 years

Chronic Rhinosinusitis with Nasal Polyposis

  • To maintain treatment of adult patients with severe chronic rhinosinusitis with nasal polyposis (CRSwNP) alongside corticosteroid medications sprayed into the nose. DUPIXENT® is for patients whose symptoms are not adequately controlled with oral corticosteroids and/or surgery.
  • It is not known if DUPIXENT® is safe and effective in children below the age of 18 years

Eosinophilic Esophagitis

  • To treat patients aged 1 year and older who weigh at least 15 kg with eosinophilic esophagitis (EoE)
  • It is not known if DUPIXENT® is safe and effective in children below the age of 1 year. There is limited information available in patients weighing less than 15 kg.

Prurigo Nodularis

  • To treat adult patients with moderate-to-severe prurigo nodularis (PN). DUPIXENT® is for patients whose symptoms are not adequately controlled with prescription creams and/or ointments, or when those treatments are not recommended. DUPIXENT® can be used with or without topical corticosteroid creams and/or ointments applied to the skin to help reduce inflammation. 
  • It is not known if DUPIXENT® is safe and effective in children below the age of 18 years

Chronic Spontaneous Urticaria 

  • To treat patients (12 years of age and older) with chronic spontaneous urticaria (CSU). DUPIXENT® is for patients whose symptoms are not adequately controlled with allergy medicines called H1 antihistamines.
  • It is not known if DUPIXENT® is safe and effective in children below 12 years old

Who should NOT use DUPIXENT®

Do not use DUPIXENT® if you are allergic to dupilumab or to any of the ingredients in DUPIXENT®.

DUPIXENT® is not a rescue medicine and should not be used to treat a sudden asthma or COPD attack (exacerbation).

Do not stop or reduce your asthma medicines, unless instructed by your doctor. These medicines (especially ones called corticosteroids) must be stopped gradually, under the direct supervision of your doctor. Rarely, patients taking DUPIXENT® may develop inflammation of blood vessels or lungs due to an increase of certain white blood cells (eosinophilia). This usually, but not always, happens in people who also take corticosteroids, which are being stopped or for which the dose is being lowered. Tell your doctor immediately if you develop a combination of symptoms such as a persistent fever, shortness of breath, chest pain, rash, and/or pins and needles or numbness of arms or legs.

DUPIXENT® can potentially cause serious side effects, including generalized allergic (hypersensitivity) reactions and anaphylactic reaction. You must look for signs or symptoms of these conditions (e.g., breathing problems, swelling of the face, lips, mouth, throat or tongue, fainting, dizziness, feeling lightheaded (low blood pressure), fever, general ill feeling, swollen lymph nodes, hives, itching, joint pain, skin rash) while you are taking DUPIXENT®. Stop taking DUPIXENT® and tell your doctor or seek medical help immediately if you notice any signs or symptoms of an allergic reaction. 

What should I tell my doctor before taking DUPIXENT®?

To help avoid side effects and ensure proper use, talk to your healthcare provider before you take DUPIXENT®. Talk about any health conditions or problems you may have, including if you:

  • Have a parasitic infection (intestinal parasites). If you already have a parasitic infection, it should be treated before you start treatment with DUPIXENT®. If you live in a region where these infections are common or if you are travelling to such a region, check with your doctor.
  • Are pregnant or plan to become pregnant. It is not known if DUPIXENT® will harm your unborn baby. Tell your healthcare provider if you become pregnant while taking DUPIXENT®.
  • Are breastfeeding or plan to breastfeed. You and your healthcare provider should decide if you will take DUPIXENT® or breastfeed. You should not do both without talking to your healthcare provider first.
  • Have other allergic conditions such as asthma and are taking asthma medicines
  • Are scheduled to receive a vaccination
  • Have eye problems (e.g., itching, redness)

You should also tell your doctor about all the medicines you take, including any drugs, vitamins, minerals, natural supplements, or alternative medicines.

DUPIXENT® and Sanofi logos are trademarks of Sanofi, used under license by sanofi-aventis Canada Inc.
REGENERON® is a trademark of Regeneron Pharmaceuticals, Inc. All rights reserved.
© 2026 sanofi-aventis Canada Inc. All rights reserved.
MAT-CA-2501555E- 1.0 - 02/2026    Last updated: February 2026

Innovative Medicines Canada PAAB

Sanofi Regeneron

DUPIXENT® (dupilumab)

Important Note
This website is intended for educational purposes and is in no way intended to substitute for professional medical advice, to contradict medical advice given, or for medical care of any kind. As with any medication, speak to your doctor before using. Please review the Terms & Conditions before using this website. Your use of this website indicates your agreement to be bound by the Terms & Conditions.